Species Differences in Metabolism of Sodium 2-[4-(2-Oxocyclopentylmethyl)-phenyl]propionate Dihydrate (Loxoprofen Sodium), a New Anti-Inflammatory Agent
スポンサーリンク
概要
- 論文の詳細を見る
Urinary metabolites of loxoprofen-^<14>C sodium were determined in rats, mice, dogs and monkeys after oral administration of the drug. In all these animal species, the cyclopentanone moiety of loxoprofen was predominantly reduced to trans-OH (an active principle), together with cis-OH (minor product). The monohydroxy metabolites were further hydroxylated in rats to the diols (M-4,M-5 and M-6), which were excreted in urine as the main metabolites. Mice excreted the monohydroxy metabolites mainly as their free forms. In dogs, the monohydroxy metabolites were conjugated with taurine and glucuronic acid, and monkeys furnished the ester glucuronides of the monohydroxy metabolites. Thus, species differences were observed both in the hydroxylation and in the conjugation reactions of the monohydroxy metabolites produced by the reduction of loxoprofen.
- 公益社団法人日本薬学会の論文
- 1983-10-25
著者
-
田中 頼久
三共(株)分析代謝研究所
-
林 了三
三共(株)分析代謝研究所
-
西川 優子
Analytical and Metabolic Research Laboratories, Sankyo Co., Ltd.
-
林 了三
Analytical and Metabolic Research Laboratories, Sankyo Co., Ltd.
-
西川 優子
Analytical And Metabolic Research Laboratories Sankyo Co. Ltd.
関連論文
- 168 気管支喘息患者における末梢血好酸球活性化の各評価法による検討
- A型MAO阻害剤RS-8359のキラルインバージョン
- Occurrence of Cysteine Conjugate of 2-Hydroxyestrone in Rat Bile, with Special Reference to Its Formation Mechanism
- プロフェン系抗炎症薬CS-670のイヌにおける立体特異的タウリン抱合
- 抗炎症薬にみる光学活性 : ロキソプロフェンの例(医薬品にみる光学活性)
- Purification and Some Properties of Ketone Reductase Forming an Active Metabolite of Sodium 2-[4-(2-Oxocyclopentylmethyl)-phenyl] propionate Dihydrate (Loxoprofen Sodium), a New Anti-inflammatory Agent, in Rabbit Liver Cytosol
- Structural Determination of Rat Urinary Metabolites of Sodium 2-[4-(2-Oxocyclopentylmethyl) phenyl] propionate Dihydrate (Loxoprofen Sodium), a New Anti-inflammatory Agent
- Optical Inversion of (2R)-to (2S)-Isomers of 2-[4-(2-Oxocyclopentylmethyl)-phenyl] propionic Acid (Loxoprofen), a New Anti-inflammatory Agent, and Its Monohydroxy Metabolites in the Rat
- Species Differences in Metabolism of Sodium 2-[4-(2-Oxocyclopentylmethyl)-phenyl]propionate Dihydrate (Loxoprofen Sodium), a New Anti-Inflammatory Agent
- Stereospecific Inversion of Configuration of 2-(2-Isopropylindan-5-yl)-propionic Acid in Rats
- Metabolic Studies on CS-359,a New β-Adrenergic Blocking Agent. I. Isolation and Identification of the Urinary Metabolites of CS-359
- Studies on the Total Synthesis of dl-Colchiceine. I. Synthesis of 3-Hydroxy-9,10,11-trimethoxy-1,2,3,4,6,7-hexahydro-5H-dibenzo [a, c] cycloheptatrien-5-one.
- 薬物代謝に関与する肝臓のケトン還元酵素 : 第284回会議研究発表要旨
- 古くて新しい薬ニトログリセリンの耐性機構は未だ不明
- A型MAO阻害剤RS-8359の立体選択的水酸化
- 薬物の体内動態とキラリティー -片方の異性体が血中に出てこない例-
- Steroid Series. XVII. New Synthetic Routes to 19-Norsteroids (1)
- Steroid Series. XVI. The Preparation of 3α, 5α-Cyclo-6β, 19-oxidosteroids and its Conversion to 19-Oxygenated Steroid Derivatives
- The Formation of 6,19-Epoxy-3,5-cyclo-steroid
- Steroid Series. VI. : Synthesis of B-Norsteroids. (2).
- Steroid Series. V. : Synthesis of B-Norsteroids. (1).
- Steroid Series. IV. : Ozonization of Cyclic 3-(Ethylene Acetal) of ⊿^4-3-oxosteroids.
- Steroid Series. III. : Ozonization of 3-Acetoxy-⊿^5-steroids in the Presence of Formaldehyde.
- Steroid Series. IX. A New Route to 6-Nitrosteroid Derivatives.
- Steroid Series. XXIII. Photolysis of Steroidal 6-Oxygenated 5,19-Lactone (β-Lactone)
- Steroid Series. XXII. Photolysis of 3α, 5-Cyclo-6β-methoxy-17β-acetoxy-5α-androstan-19-one
- Steroid Series. XIX. Rearrangement Reactions of 3β-Acetoxy-6,19-dioxo-5α-steroids
- Steroid Series. XVIII. Acid-Catalysed Rearrangement Product of 3α, 5α-Cyclo-6,19-dioxosteroid and its Conversion to 19-Nor-A-homotestosterone